Coronavirus (COVID-19) Business Continuity Plans

As the novel coronavirus (COVID-19) spread continues to increase around the world, Esperite is committed to providing a safe environment for our employees and partners, ensuring business continuity, to the best of our abilities.

Therefore, we are confident that coronavirus will not significantly impact the development of Esperite’s projects.

We are taking increased measures to maintain business continuity and protect the health of our employees.

  • All business travel are cancelled and we recommended that our team avoids non-urgent personal travel as well.
  • We require any employee that boards an aircraft to work from home for a 14-day precautionary period before coming back to the office.
  • Visitors are no longer accepted to our offices and we have canceled all planned events, parties, meet-ups, and conferences.
  • We have shared best practice health tips with our team and continue to keep them updated on a daily basis.

Esperite has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.

Consequently, Esperite becomes an established investment group which focuses on  the health care segment and the biotechnology activities. With more than 20 years of experience, Esperite operates now a light and efficient structure dedicated to growth and active development.


Long experience of investments, diversity and risk management

Esperite capitalise on its experience over the last 20 years of existence. Above all, Esperite is now an investment company with a strict focus on short to mid-term profitability and value creation for its shareholders

Best Scientific and Financial Professionals

Esperite doesn’t want to invest in fundamental research. Furthermore, its goals are realistic, based on proven technologies, with a concrete background and a high potential to access the commercial markets

Advanced Research

Esperite believes in short term return on investment and has a focus on translational medicine which provides direct access to the patients direct access to the latest technologies

Global Perspective

Esperite wants to consider any opportunity as a challenge for the benefit of its shareholders. As a result, Esperite wants to create a network of reputable partners and establish partnership with a selection of them




Stock Ticker